Celularity Inc. Announces Private Placement of Series A Convertible Preferred Stock

On October 24, 2025, Celularity Inc. entered into a Securities Purchase Agreement with an institutional investor for a private placement of Series A Convertible Preferred Stock. The agreement involves the issuance of up to $6,666,667 in aggregate stated value of Series A Preferred Stock and accompanying warrants to purchase shares of Class A Common Stock. The Series A Preferred Stock will be issued at 90% of the stated value, with each share having a stated value of $1.111111. The warrants will be issued for no additional consideration and will entitle the investor to purchase shares of Common Stock at an initial exercise price of $3.00 per share. The transaction is expected to provide the company with approximately $2 million in gross proceeds, which will be used for working capital and general corporate purposes. The company also entered into a Registration Rights Agreement, Security Agreement, and Exchange Promissory Note as part of the transaction.